Mr. Shawn Moniz reports

CANNVAS SIGNS STRATEGIC DATA AND ANALYTICS LOI WITHIN HEMP SECTOR

Cannvas Medtech Inc. and Natures Hemp Inc. have signed a letter of intent to negotiate, in good faith, a data analytics agreement, for which Cannvas will provide industry insight and analytical modelling capabilities to Natures Hemp business models and key performance indicators (KPIs).

"Natures Hemp is on the leading edge of the emerging hemp economic ecosystem and recognizes the importance of consumer data and both market and industry analysis as a core component and key driver of its business models," said Shawn Moniz, chief executive officer, Cannvas Medtech. "Truly knowing your customer is invaluable when applying a targeted approach to high-value customer-based segments within your industry. Companies like Natures Hemp will benefit from partnering with our data and analytics division by using industry insights for planning and product development. Natures Hemp will benefit by using our proprietary data algorithms to determine the appropriate product mix and product release schedule to maximize company revenue potential. Cannvas Data will gain important access to Natures Hemp (a hemp industry first for Cannvas) product database and industry targeting data, further enriching our data sets of both the cannabis and hemp consumer markets."

Under the terms of the agreement, Cannvas will develop specific parameters within its existing Cannvas Data framework to collect data and analytics from Natures Hemp and its strategic partnerships, and Natures Hemp gains access to a broad data set as it presses forward in the hemp sector and becomes a stand-alone public company. This agreement will allow Natures Hemp to bring the right products to market, at the right time, to the right individuals that will maximize Natures Hemp customer conversion funnel.

Cannvas Data is the analytics branch of Cannvas Medtech. Its mission is to collect data from various credible sources to enhance user persona data algorithms for Cannvas.me. Cannvas Data will leverage existing databases, site traffic and advanced technology for marketing purposes, and will leverage its comprehensive solution for the global hemp community. The companies have agreed to a discovery period whereby the technological specifications of the connectivity will be set up by Cannvas Data, and will work together toward a definitive partnership agreement within the next 45 days.

The letter of intent between the two companies comes after a wide-ranging agriculture and food policy legislation known as the Farm Bill, passed in the United States Senate by a vote of 86 to 11 on June 28, 2018. The bill contains provisions to legalize the cultivation, processing and sale of industrial hemp. In April, Senate majority leader Mitch McConnell (Republican, Ky.) introduced stand-alone legislation to legalize hemp and make hemp plants eligible for crop insurance, the Hemp Farming Act, which were included in the larger Farm Bill. If and when receiving final approval, the non-psychoactive form of cannabis would finally become legal to grow in the United States after a long absence.

About Cannvas Medtech Inc.

Cannvas Medtech is a leading business technology company within the cannabis space. The company designs and builds customer-centric solutions that enable its partners to harness the power of data to truly understand their customers, industry and key business drivers.

We seek Safe Harbor.